ADIPOQ and coronary artery disorder: Furthermore, mRNA levels of adiponectin and plasma adiponectin are reduced in adipose tissue of patients with obesity and T2DM or coronary artery disease, suggesting that hypoadiponectinemia may contribute to the pathogenesis of the development of NAFLD from steatosis to steatohepatitis (55).